FDA Adverse Event Injury Summary report: N

ASAHI APS DIALYZERS

MDR report key: 2992221 · Received March 1, 2013

Report

Report Number
8010002-2013-00140
Event Type
Injury
Date Received
March 1, 2013
Date of Event
June 21, 2007
Report Date
February 25, 2013
Manufacturer
ASAHI KASEI MEDICAL CO., LTD.
Product Code
KDI
PMA / PMN Number
K051187
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
BIOMEDICAL ENGINEER

Narratives

Additional Manufacturer Narrative · 1

THIS INCIDENT OCCURRED IN (B)(6) AND IS REPORTED TO FDA ACCORDING TO THE REQUIREMENT. APS-15SA IS IDENTICAL MODEL TO REXEED-15S SERIES MARKETED IN US. FROM THE ANALYSIS RESULT, IT IS DIFFICULT TO CONCLUDE THERE WERE ANY ABNORMALITIES ON PERFORMANCE OF THE DIALYZER AND THE DIALYZER ITSELF. WE ALSO REVIEWED MANUFACTURING RECORDS, QUALITY RECORDS OF LOT #07ZW13. AS A RESULT, NO ABNORMALITY WAS FOUND IN RECORDS. THE 10,785 UNITS OF THIS LOT #07ZW13 WERE DISTRIBUTED TO THE MEDICAL FACILITIES AND NO SIMILAR EVENT USING THIS LOT #07ZW13 WAS REPORTED GLOBALLY. THE SYMPTOMS OBSERVED IN THE EVENTS ARE CONSIDERED TO BE A DIALYZER REACTION. NOTE: THE DIALYZER REACTION IS A BROAD GROUP OF EVENTS THAT INCLUDE BOTH ANAPHYLACTIC AND LESS WELL- DEFINED ADVERSE REACTIONS OF UNKNOWN CAUSE. "HANDBOOK OF DIALYSIS 4TH ED." JOHN T DAUGIRDAS ET. AL., LIPPINCOTT, WILLIAMS & WILKINS, 2006.

Description of Event or Problem · 1

ON (B)(6) 2007: THE DIALYZER (APS-15SA) WAS USED FOR HEMODIALYSIS. IMMEDIATELY BLOOD PRESSURE DECREASED (SYSTOLIC BLOOD PRESSURE: 115=>54MMHG), VOMITING, TACHYCARDIA, RASH AND DYSPNEA OCCURRED. AFTER THE ONSET OF THESE ADVERSE EVENTS, OXYGEN 10L, PHYSIOLOGICAL SALINE 400ML, DEXAMETHASONE SODIUM PHOSPHATE, DEXTRAN 40/LACTATE RINGER SOLUTION 500ML AND DOPAMINE HYDROCHLORIDE WERE ADMINISTERED. THEN BLOOD PRESSURE RECOVERED AND OTHER SYMPTOMS DISAPPEARED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
88779 ASAHI APS DIALYZERS KDI ASAHI KASEI MEDICAL CO., LTD. APS-15SA 07ZW13

Patients

Seq Age Sex Outcome Treatment
1 69 YR Life Threatening FUTHAN (NAFAMSTAT MESYLATE)